Abiopharma

New Form 8-K - Vigil Neuroscience, Inc. Filed: 2025-08-05 AccNo: 0001193125-25-173134 Size: 397 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.03: Material Modifications to Rights of Security Holders …

New Form 8-K - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-08-05 AccNo: 0001437749-25-024720 Size: 178 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 424B3 - InMed Pharmaceuticals Inc. Filed: 2025-08-05 AccNo: 0001213900-25-071758 Size: 2 MB

New Form 8-K - InspireMD, Inc. Filed: 2025-08-05 AccNo: 0001641172-25-022159 Size: 14 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 10-Q - Imunon, Inc. Filed: 2025-08-05 AccNo: 0001493152-25-011598 Size: 5 MB

New Form 8-K - Corbus Pharmaceuticals Holdings, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102447 Size: 425 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 10-Q - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-08-05 AccNo: 0001628280-25-037613 Size: 7 MB

New Form 6-K - ONCOLYTICS BIOTECH INC Filed: 2025-08-05 AccNo: 0001129928-25-000059 Size: 30 KB

New Form DEFA14A - STAAR SURGICAL CO Filed: 2025-08-05 AccNo: 0001193125-25-173111 Size: 66 KB

New Form 10-Q - Cogent Biosciences, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102440 Size: 10 MB